Skip to main content

Vanderbilt Ingram Cancer Center Archives

Study finds new genetic susceptibilities for colon cancer

Sep. 12, 2023—Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer. 

Read more


Foundation funds research to block drug resistance in cancer treatment

Sep. 1, 2023—The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.

Read more


Vanderbilt-Ingram Cancer Center hosts Korean American Symposium

Aug. 17, 2023—Vanderbilt-Ingram Cancer Center recently hosted the first of a planned series of events to highlight the diversity of oncology researchers and to nurture networking opportunities for them.

Read more


New leaders named to Vanderbilt-Ingram research programs

Aug. 10, 2023—Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.

Read more


Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

Aug. 8, 2023—A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.

Read more


International workgroup of geneticists issues CHEK2 guidelines

Jul. 26, 2023—International workgroup issues additional guidance on how to manage patients who carry inherited CHEK2 gene mutations that put them at a higher risk for cancer.

Read more


Stem cell recipient meets donor who saved her life 10 years ago

Jul. 20, 2023—Each passing day is precious for Deneen Eastridge, but a decade is a priceless gift. The Dallas resident came to Nashville recently to meet Trina Hughes, the stem cell donor who gave her the gift of life 10 years ago.

Read more


Holowatyj receives National Cancer Institute MERIT Award

Jul. 19, 2023—Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.

Read more


Study identifies key regulator of melanoma development

Jun. 29, 2023—Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity.

Read more


New treatment option for metastatic colorectal cancer prolongs survival

Jun. 15, 2023—Research conducted at Vanderbilt points to a new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

Read more


Early-onset CRC germline genetic differences identified by race, ethnicity

Jun. 15, 2023—A Vanderbilt study that delved into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants.

Read more


Study discovers that tumor mutation burden predicts survival outcome

Jun. 5, 2023—The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more